Aeolus Pharmaceuticals Inc. announced consolidated earnings results for the fourth quarter and full year ended September 30, 2014. For the fourth quarter of fiscal year 2014, total revenues were $2,417,000 as compared to $883,000 in the fourth quarter of fiscal year 2013. Net loss for the fourth quarter in fiscal year of 2014 was $524,000 or ($0.0/share) as compared to $668,000 or ($0.0/share) in the fourth quarter of fiscal year 2013.

For the year, the company reported contract revenue of $9,631,000 compared to $3,928,000 a year ago. Loss from operations was $80,000 compared to $2,698,000 a year ago. Net loss was $80,000 or $0.00 per basic and diluted share compared to $3,208,000 or $0.03 per basic and diluted share a year ago. Net loss attributable to common stockholders was $80,000 compared to $3,208,000 a year ago. Net cash provided by operating activities was $323,000 compared to net cash used in operating activities of $2,970,000 a year ago.